A new study by McGill University’s Dr. Gabriella Gobbi reveals the neurobiological mechanisms by which LSD could relieve anxiety.
Peyton Nyquvest is the CEO of Numinus, a Canadian publicly-traded company that is involved in psychedelic synthesis, research and treatment. Numinous recently...
The article News You Might Have Missed: April 24th, 2023 was originally published on Microdose. Welcome to the News You Might Have Missed, a weekly roundup...
VANCOUVER – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF), a biotechnology company and global leader in first-in-class psilocybin-based...
The article News You Might Have Missed: April 17th, 2023 was originally published on Microdose. Welcome to the News You Might Have Missed, a weekly roundup...
Filament Health Corp. (OTCQB: FLHLF / NEO: FH / FSE: 7QS), a clinical-stage natural psychedelic drug development company, and PharmAla Biotech Holdings...
Company plans to focus on alcohol use disorders. The post Clearmind Medicine Raises $3.5 Million appeared first on Green Market Report.
The article Ketamine Wellness Centers Re-Opening? Delic Holdings Signs LOI with Peter/PetraMD was originally published on Microdose. We’ve been covering...
The company made $364,500 in licensing revenues. The post Psychedelic Research Firm Filament Health Grows Pipeline in 2022 appeared first on Green Market...
The article News You Might Have Missed: April 3rd, 2023 was originally published on Microdose. Welcome to the News You Might Have Missed, a weekly roundup...